RT @AshimaMakol: ð¥Continued, More Clinically Meaningful data in #SSc #ILD from #Nintedanib in >52 wk SENSCIS &

Social Author Image

https://pbs.twimg.com/profile_images/1225811658255282178/SJTqzDp5.jpg

Tweet Author

Social Author Name

Ashima Makol MD

Tweet Content

🔥Continued, More Clinically Meaningful data in #SSc #ILD from #Nintedanib in >52 wk SENSCIS & SENSCIS-ON(open-label ext)#ACR21 Dr Distler ✨MMF likely to stay 1st line, then Nintedanib ❓Is it time for MMF + Antifibrotic upfront?? Await SLS-III;Data so far seems supportive https://t.co/JWXMlsJgmc

Show on Archive Page

On

Display in Search Results

On

PDQ

Off

Topics

RT @AshimaMakol: ð¥Continued, More Clinically Meaningful data in #SSc #ILD from #Nintedanib in >52 wk SENSCIS &

Do you get our email newsletter?

RT @AshimaMakol: ð¥Continued, More Clinically Meaningful data in #SSc #ILD from #Nintedanib in &gt;52 wk SENSCIS &amp;

RT @AshimaMakol: ð¥Continued, More Clinically Meaningful data in #SSc #ILD from #Nintedanib in >52 wk SENSCIS &